Immediate Impact
38 standout
Citing Papers
Resistance mechanisms to immune checkpoint inhibitors: updated insights
2025 Standout
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy
2025 Standout
Works of Mansi Shah being referenced
LINKER-MM1 study: Linvoseltamab (REGN5458) in patients with relapsed/refractory multiple myeloma.
2023
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mansi Shah | 97 | 41 | 92 | 63 | 33 | 278 | |
| Daryl Kai Ann Chia | 58 | 23 | 68 | 28 | 31 | 322 | |
| Chun Feng | 77 | 62 | 95 | 42 | 19 | 294 | |
| Mahomed A. Dada | 73 | 46 | 58 | 37 | 27 | 330 | |
| Maeve P. Crowley | 36 | 4 | 63 | 11 | 31 | 293 | |
| F R Vicary | 38 | 19 | 52 | 5 | 25 | 309 | |
| Gagangeet Sandhu | 42 | 21 | 64 | 11 | 31 | 294 | |
| J M Benítez | 61 | 16 | 60 | 3 | 30 | 312 | |
| William G. Anlyan | 39 | 10 | 67 | 17 | 35 | 330 | |
| Yosuke Inaba | 37 | 14 | 43 | 10 | 37 | 207 | |
| Douglas Wilson | 53 | 11 | 89 | 22 | 29 | 306 |
All Works
Login with ORCID to disown or claim papers
Loading papers...